Non-nucleoside reverse transcriptase inhibitors
Nevirapine
The FDA lists this product in 31 strengths and forms.
Composition
- Active ingredients
- NEVIRAPINE 400MG
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- NEVIRAPINE 200MG · TabletANDA077429-001 · Tentative approval
- NEVIRAPINE 50MG/5ML · SuspensionANDA077702-001 · Prescription
- NEVIRAPINE 200MG · TabletANDA077956-001 · Prescription
- NEVIRAPINE 200MG · TabletANDA078644-001 · Discontinued
- NEVIRAPINE 200MG · TabletANDA078887-001 · Tentative approval
- NEVIRAPINE 200MG · TabletANDA202523-001 · Prescription
- NEVIRAPINE 400MG · Tablet, extended releaseANDA205258-001 · Discontinued
- NEVIRAPINE 100MG · Tablet, extended releaseANDA206271-001 · Discontinued
- NEVIRAPINE 400MG · Tablet, extended releaseANDA205921-001 · Tentative approval
- NEVIRAPINE 400MG · Tablet, extended releaseThis page
- NEVIRAPINE 200MG · TabletANDA203021-001 · Discontinued
- NEVIRAPINE 200MG · Tablet